{
    "Trade/Device Name(s)": [
        "HemosIL Factor II Deficient Plasma"
    ],
    "Submitter Information": "Instrumentation Laboratory Co.",
    "510(k) Number": "K050661",
    "Predicate Device Reference 510(k) Number(s)": [
        "K900133",
        "K002400"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "GJT"
    ],
    "Summary Letter Date": "May 2, 2005",
    "Summary Letter Received Date": "March 15, 2005",
    "Submission Date": "March 14, 2005",
    "Regulation Number(s)": [
        "21CFR864.7290"
    ],
    "Regulation Name(s)": [
        "Factor Deficiency Test"
    ],
    "Analyte Class(es)": [
        "hematology",
        "coagulation"
    ],
    "Analyte(s)": [
        "Factor II"
    ],
    "Specimen Type(s)": [
        "Citrated plasma"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "IL Coagulation Systems",
        "ELECTRA Systems",
        "ACL 300",
        "ACL 6000",
        "ACL 9000",
        "ACL TOP",
        "E1600C",
        "ACL Futura",
        "ELECTRA 1600C"
    ],
    "Method(s)/Technology(ies)": [
        "Prothrombin time (PT) assay"
    ],
    "Methodologies": [
        "Modified prothrombin time test"
    ],
    "Submission Type(s)": [
        "Reagent"
    ],
    "Document Summary": "FDA 510(k) summary for HemosIL Factor II Deficient Plasma, a reagent for quantitative determination of factor II activity via PT assay in citrated plasma on IL Coagulation and ELECTRA Systems.",
    "Indications for Use Summary": "Intended for in vitro diagnostic quantitative determination of factor II activity in citrated plasma using a PT assay on IL Coagulation and ELECTRA Systems.",
    "fda_folder": "Hematology"
}